Anatomical Therapeutic Chemical Classification System
Tacrolimus is a highly potent immunosuppressive agent. In particular, tacrolimus inhibits the formation of cytotoxic lymphocytes, which are mainly responsible for graft rejection. Tacrolimus suppresses T-cell activation and T-helper-cell dependent B-cell proliferation, as well as the formation of lymphokines (such as interleukins-2, -3, and γ-interferon) and the expression of the interleukin-2 receptor.
France Italy Spain United Kingdom
Austria Finland Netherlands
Australia Austria Canada Cyprus Finland ...
Austria Finland Lithuania Netherlands Poland ...
Austria Canada Finland France Ireland ...
Austria Finland France Ireland Lithuania ...
Australia Austria Brazil Canada Cyprus ...
Austria Ireland Italy Lithuania Poland ...
Austria Italy Poland Spain